In silico studies toward the discovery of new anti-HIV nucleoside compounds with the use of TOPS-MODE and 2D/3D connectivity indices. 1. Pyrimidyl derivatives

Journal of Chemical Information and Computer Sciences

Volumn 42, Issue 5, 2002, Pages 1194-1203

  Estrada, Ernesto ^a   Vilar, Santiago ^a   Uriarte, Eugenio ^a   Gutierrez, Yaquelin ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE COMPOUNDS;

DERIVATIVES; DRUG PRODUCTS; MOLECULAR STRUCTURE; OPTIMIZATION; PROBABILITY;

NUCLEIC ACIDS;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NUCLEOSIDE;

ARTICLE; CHEMICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; DRUG DESIGN; HUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANTI-HIV AGENTS; COMPUTER SIMULATION; DRUG DESIGN; HUMANS; MODELS, CHEMICAL; NUCLEOSIDES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036708531     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci0255331     Document Type: Article

References (82)

1. Schinazi, R.F. Competitive inhibitors of human immunodeficiency virus reverse transcriptase. Persp. Drug Discuss. Des. 1993, 1, 151-180.
2. De Clercq, E. Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections. J. Med. Chem. 1995, 38, 2492-2517.
3. Mansour, T.S.; Storer, R. Antiviral nucleosides. Curt. Pharm. Des. 1997, 3, 227-264.
4. el Kouni, M.H. Trends in the design of nucleoside analogues as anti-HIV drugs. Curt. Pharm. Des. 2002, 8, 581-593.
5. Yates, P.C.A molecular modeling study of nucleoside analogues as potential anti-AIDS drugs. Struct. Chem. 1991, 2, 611-619.
6. Pepe, G.; Meyer, M.; Faury, P.; Graciet, J.C.; Chermann, J.C.; Kraus, J.L.A model allowing the design of modified nucleosides as HIV-RT inhibitors. Eur. J. Med. Chem. 1996, 31, 775-786.
7. Dimoglo, A.S.; Gorbachov, M.Y.; Lesnik, T.I.; Saracoglu, M.; Guzel, Y.; Yildrim, I. Investigation of the relationship between chemical structure and anti-HIV-1 activity in a class of nucleoside analogues: electron-topological approach. Curr. Med. Chem. 1997, 4, 23-34.
8. Garg, R.; Gupta, S.P.; Gao, H.; Babu, M.S.; Debnath, A.K.; Hansch, C. Comparative quantitative structure-activity relationships studies on anti-HIV drugs. Chem. Rev. 1999, 99, 3525-3601.
9. Mickle, T.; Nair, V. Predictive QSAR analysis of anti-HIV agents. Drugs Future 2000, 25, 393-400.
10. Estrada, E.; Uriarte, E. Recent advances on the role of topological indices in drug discovery research. Curt. Med. Chem. 2001, 8, 1573-1588.
11. Estrada, E. On the topological sub-structural molecular design (TOSS-MODE) in QSPR/QSAR and drug design research. SAR QSAR Environ. Res. 2000, 11, 55-73.
12. Estrada, E. Spectral moments of the edge adjacency matrix in molecular graphs. 1. Definition and applications to the prediction of physical properties of alkanes. J. Chem. Inf. Comput. Sci. 1996, 36, 844-849.
13. Estrada, E. Spectral moments of the edge adjacency matrix in molecular graphs. 2. Molecules containing heteroatoms and QSAR applications. J. Chem. Inf. Comput. Sci. 1997, 37, 320-328.
14. Estrada, E. Spectral moments of the edge adjacency matrix in molecular graphs. 3. Molecules containing cycles. J. Chem. Inf. Comput. Sci. 1998, 38, 23-27.
15. Estrada, E.; Gutierrez, Y. Modeling chromatographic parameters by a novel graph theoretical sub-structural approach. J. Chromatogr. A 1999, 858, 187-199.
16. Estrada, E., Peña, A.; García-Domenech, R. Designing sedative/hypnotic compounds from a novel substructural graph-theoretical approach. J. Comput.-Aided Mol. Des. 1998, 12, 583-595.
17. Estrada, E., Uriarte, E., Montero, A., Teijeira, M., Santana, L.; De Clercq, E. A novel approach to the rational selection and design of anticancer compounds. J. Med. Chem. 2000, 43, 1975-1985.
18. Estrada, E.; Peña, A. In Silico studies for the rational discovery of anticonvulsant compounds. Bioorg. Med. Chem. 2000, 8, 2755-2770.
19. Estrada, E.; Uriarte, E. Quantitative structure-toxicity relationships using TOPS-MODE, 1. Nitrobenzene toxicity to Tetrahymena pyriformis. SAR QSAR Environ. Res. 2001, 12, 309-324.
20. Estrada, E.; Molina, E.; Uriarte, E. Quantitative structure-toxicity relationships using TOPS-MODE. 2. Neurotoxicity of a noncongeneric series of solvents. SAR QSAR Environ. Res. 2001, 12, 445-459.
21. De Clercq, E. HIV inhihitors targeted at the reverse transcriptase. AIDS Res. Hum. Retroviruses 1992, 8, 119-134.
22. De Clercq, E.; Van Aerschot, A.; Herdewijn, P.; Baba, M.; Pauwels, R.; Balzarini, J. Anti-HIV-1 activity of 2′,3′-dideoxynucleoside analogues: structure-activity relationship. Nucleosides Nucleotides 1989, 8, 659-671.
23. Dechaux, E.; Pontikis, R.; Monneret, C. Efficient synthesis of N-4 alkyl derivatives of 2′,3′-dideoxycytidine (ddC). Nucleosides Nucleotides 1999, 18, 1-4.
24. De Clercq, E. Perspectives for the chemotherapy of HIV infection: an introduction; Pharmacochem. Libr.: 1990; Vol. 14 (Des. Anti-AIDS Drugs), pp 1-24.
25. Abdel-Rahman, A.A.-H.; Abdel-Bary, H.M.; Pedersen, E.B.; Nielsen, C. Synthesis of 4-methylthio analogues of FLT and AZT and their evaluation against HIV. Arch. Pharm. 1995, 328, 67-70.
26. Fedorov, I.I.; Kazmina, E.M.; Gurskaya, G.V.; Jasko, M.V.; Zavodnic, V.E.; Balzarini, J.; De Clercq, E.; Faraj, A., Sommadossi, J.-P.; Imbach, J.-L.; Gosselin, G. Novel 3′-C/N-substituted 2′,3′-β-D-dideoxynucleosides as potential chemotherapeutic agents. 1. Thymidine derivatives: Synthesis, structure, and broad spectrum antiviral properties. J. Med. Chem. 1997, 40, 486-494.
27. Lavaire, S.; Plantier-Royon, R.; Portella, C.; De Monte, M.; Kirn, A.; Aubertin, A.-M. 3′-Deoxy-3′-C-trifluoromethyl nucleosides: synthesis and antiviral evaluation. Nucleosides Nucleotides 1998, 17, 2267-2280.
28. Ichikawa, E.; Yamamura, S.; Kato, K. Synthesis of 2′,3′-dideoxy-3′-C-(hydroxymethyl)-4′-thiopentofuranosyl nucleosides as potential antiviral agent. Bioorg. Med. Chem. Lett. 1999, 9, 1113-1114.
29. Herdewijn, P.; Balzarini, J.; Baba, M.; Pauwels, R.; Van Aerschot, A.; Janssen, G.; De Clercq, E. Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides. J. Med. Chem. 1988, 31, 2040-2048.
30. Jeong, L.K.; Lee, Y.A.; Moon, H.R.; Chun, M.W. Synthesis and antiviral activity of apio dideoxy nucleosides with azido or amino substituent. Nucleosides Nucleotides 1998, 17, 1473-1487.
31. Jeon, G.S.; Nair, V. New isomeric analogues of anti-HIV active azidonucleosides. Tetrahedron 1996, 52, 12643-12650.
32. Hiebl, J.; Zbiral, E.; Balzarini, J.; De Clercq, E. Side-chain derivatives of biologically active nucleosides. 1. Side-chain analogues of 3′-azido-3′-deoxythymidine (AZT). J. Med. Chem. 1992, 35, 3016-3023.
33. Schinazi, R.F.; Chu, C.K.; Peck, A.; McMillan, A.; Mathis, R.; Cannon, D.; Jeong, L.S.; Beach, J.W.; Choi, W.B.; Yeola, S. Activities of the four optical isomers of 2′,3′-dideoxy-3′-thiacytidine (BCH-189) against human immunodeficiency vires type 1 in human lymphocytes. Antimicrob. Agents Chem. 1992, 36, 672-676.
34. Mansour, T.S.; Evans, C.A.; Siddiqui, M.A.; Charron, M.; Zacharie B.; Nguyen-Ba, N.; Lee, N.; Korba, B. Structure-activity relationship of pyrimidine heterosubstituted nucleoside analogues. Nucleosides Nucleotides 1997, 16, 993-1001.
35. Kim, H.O.; Ahn, S.K.; Alves, A.J.; Beach, J.W.; Jeong, L.S.; Choi, B.G,; Van Roey, P.; Schinazi, R.F.; Chu, C.K. Asymmetric synthesis of 1,3-dioxolane-pyrimidine nucleosides and their anti-HIV activity. J. Med. Chem. 1992, 35, 1987-1995.
36. Wilson, L.J.; Choi, W.B.; Spurling, T.; Liotta, D.C.; Schinazi, R.F.; Cannon, D.; Painter, G.R.; St. Clair, M.; Furman, P.A. The synthesis and anti-HIV activity of pyrimidine dioxolanyl nucleosides. Bioorg. Med. Chem. Lett. 1993, 3, 169-74.
37. Belleau, B.; Brasili, L.; Chan, L.; DiMarco, M.P.; Zacharie, B.; Nguyen Ba, N.; Jenkinson, H.J.; Coates, J.A.V.; Cameron, J.M. A novel class of 1,3-oxathiolane nucleoside analogues having potent anti-HIV activity. Bioorg. Med. Chem. Lett. 1993, 3, 1723-1728.
38. Schinazi, R.F. Schinazi, R.F.; McMillan, A.; Cannon, D.; Mathis, R.; Lloyd, R.M.; Peck, A.; Sommadossi, J.P.; St Clair, M.; Wilson, J.; Furman, P.A. Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxy-methyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob. Agents Chem. 1992, 36, 2423-31.
39. Mansour, T.S.; Jin, H.; Wang, W.; Hooker, E.U.; Ashman, C.; Cammack, N.; Salomon, H.; Belmonte, A.R.; Wainberg, M.A. Antihuman immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2′-deoxy-3′-oxa-4′-thiocytidine and their 5-fluoro analogues in vitro. J. Med. Chem. 1995, 38, 1-4.
40. Nomura, M.; Shuto, S.; Tanaka, M.; Sasaki, T.; Mori, S.; Shigeta, S.; Matsuda, A. Nucleosides and nucleotides. 185. Synthesis and biological activities of 4′alpha-C-branched-chain sugar pyrimidine nucleosides. J. Med. Chem. 1999, 42, 2901-2908.
41. Sugimoto, I.; Shuto, S.; Mori, S.; Shigeta, S.; Matsuda, A. Nucleosides and nucleotides. 183. Synthesis of 4′-alpha-branched thymidines as a new type of antiviral agent. Bioorg. Med. Chem. Lett. 1999, 9, 385-388.
42. Mansour, T.S.; Jin, H. Synthesis of (±)-1′-aza-carbocyclic-pyrimidine-2′. 3′-dideoxynueleoside analogues as potential anti-HIV agents. Bioorg. Med. Chem. Lett. 1991, 1, 757-760.
43. Verheggen, I.; Van Aerschot, A.; Van Meervelt, L.; Rozenski, J.; Wiebe, L.; Snoeek, R.; Andrei, G.; Balzarini, J.; Claes, P.; et al. Synthesis, biological evaluation, and structure analysis of a series of new 1,5-anhydrohexitol nucleosides. J. Med. Chem. 1995, 38, 826-835.
44. Coates, J.A.; Cammack, N.; Jenkinson, H.J.; Jowett, A.J.; Jowett, M.I.; Pearson, B.A.; Penn, C.R.; Rouse, P.L.; Viner, K.C.; Cameron, J.M. (-)-2′-Deoxy-3′-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro. Antimicrob. Agents Chem. 1992, 36, 733-739.
45. Camara, F.; Cinrea, A.; Delbederi, Z.; Fossey, C.; Fontaine, G.; Gavriliu, D.; Jouenne, J.; Laduree, D.; Aubertin, A.M.; Kirn, A. Synthesis of L-analogues of 1-(2′, 3′-dideoxy-β-D-glyceropent-2-enofuranosyl)thymine. Pharm. Pharmacol. Commun. 1999, 5, 225-231.
46. Highcock, R.M.; Hilpert, H.; Myers, P.L.; Roberts, S.M.; Storer, R. The potential for using carbocyclic nucleosides for the treatment of AIDS. Part 1. Preparation of some analogues for azidothymidine (AZT). J. Chem. Soc., Perkin Trans. 1 1991, 1127-1134.
47. Tronchet, J.M.J.; Zsely, M.; Capek, K.; Del Villedon de Naide, F. Synthesis and anti-HIV activity of 3′-deoxy-3′-(hydroxyamino) analogues of nucleosides. Bioorg. Med. Chem. Lett. 1992, 2, 1723-178.
48. Chu, C.K.; Schinazi, R.F.; Ahn, M.K.; Ullas, G.V.; Gu, Z.P. Structure-activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type 1 in peripheral blood mononuclear cells. J. Med. Chem. 1989, 32, 612-617.
49. Kovacs, T.; Parkanyi, L.; Pelczer, I.; Cervantes-Lee, F.; Pannell, K.H.; Torrence, P.F. Solid-state and solution conformation of 3′-amino-3′-deoxythymidine, precursor to a noncompetitive inhibitor of HIV-1 reverse transcriptase. J. Med. Chem. 1991, 34, 2595-2600.
50. Gavriliu, D.; Fossey, C.; Fontaine, G.; Benzaria, S.; Ciurea, A.; Delbederi, Z.; Lelong, B.; Laduree, D.; Aubertin, A.M.; Kirn, A. Synthesis and antiviral activity of C-5 substituted analogues of d4T bearing methylamino-or methyldiamino-linker arms. Nucleosides, Nucleotides Nucleic Acids 2000, 19, 1017-1031.
51. Kozak, J.; Johnson, C.R. Synthesis of 4′-trifluoromethyl nucleoside analogues. Nucleosides Nucleotides 1998, 17(12), 2221-2239.
52. Jeong, L.S.; Yoo, S.J. Synthesis and antiviral activity of novel isodideoxy nucleosides with exocyclic methylene. Bioorg. Med. Chem. Lett. 1998, 8, 847-852.
53. Adams, D.R.; Perez, C.; Maillard, M.; Florent, J.C.; Evers, M.; Henin, Y.; Litvak, S.; Litvak, L.; Monneret, C.; Grierson, D.S. Preparation and anti-HIV activity of N-3-snbstituted thymidine nucleoside analogues. J. Med. Chem. 1997, 40, 1550-1558.
54. Kitade, Y.; Suzuki, A.; Hirota, K.; Maki, Y.; Nakane, H.; Oho, K.; Baba, M.; Shigeta, S. Synthesis and anti-human immunodeficiency virus type 1 (HIV-1) activity of 3-substituted derivatives of 3′-azido-3′-deoxythymidine (AZT), and inhibition of HIV-1 reverse transcriptase by their 5′-triphosphates. Chem. Pharos. Bull. 1992, 40, 920-924.
55. Motura, M.; Salomon, H.; Moroni, G.; Wainberg, M.; Brinon, M.C. Synthesis, lipophilicity and anti-HIV activity of a new brominated analogue of zidovudine. Nucleosides Nucleotides 1999, 18, 337-351.
56. Santana, L.; Teijeira, M.; Uriarte, E.; Balzarini, J.; De Clercq, E. Synthesis and antiviral activity of 1,2-carbonucleosides. Nucleosides Nucleotides 1995, 14, 521-523.
57. Molas, M.P.; Matheu, M.I.; Castillon, S.; Isac-Garcia, J.; Hernandez-Mateo, F.; Calvo-Flores, F.G.; Santoyo-Gonzalez, F. Synthesis of 3,6-anhydro sugars from cyclic sulfites and sulfates and their applications in the preparation of bicyclo nucleoside analogues of ddC and ddA. Tetrahedron 1999, 55, 14649-14664.
58. Maag, H.; Rydzewski, R.M. An allylic azide route to 4′-azido carbocyclic nucleosides. Synthesis of (±)-(1′a, 2′a, 3′b)-and (±)-(1′a, 2′b, 3′b)-1-[1-azido-2-hydroxy-1-(hydroxymethyl)-3-cyclopentyl]-thymine. J. Org. Chem. 1992, 57, 5823-5831.
59. Ferguson, L.N. The modern structural theory of organic chemistry; Englewoods Cliffs: Prentice-Hall: 1963.
60. Randić, M. On characterization of molecular branching. J. Am. Chem. Soc. 1975, 97, 6609-6615.
61. Kier, L.B.; Hall, L.H. Molecular Connectivity in Chemistry and Drug Research; Academic Press: New York, 1976.
62. Kier, L.B.; Hall, L.H. Molecular Connectivity in Structure-Activity Analysis; Research Studies Press: Letchworth, 1986.
63. Hall, L.H.; Kier, L.B. Molecular connectivity chi indices for database analysis and structure-property modeling. In Topological Indices and Related Descriptors in QSAR and QSPR; Devillers, J., Balaban, A.T., Eds.; Gordon and Breach: Amsterdam, The Netherlands, 1999; pp 307-360.
64. Estrada, E. Edge adjacency relationships and a novel topological index related to molecular volume. J. Chem. Inf. Comput. Sci. 1995, 35, 31-33.
65. Estrada, E. Guevara, N. Gutman, I. Extensión of edge connectivity index. Relationships to line graph indices and QSPR applications. J. Chem. Inf. Comput. Sci. 1998, 38, 428-431.
66. Estrada, E.; Rodriguez, L. Edge-connectivity indices in QSPR/QSAR studies. 1. Comparison to other topological indices in QSPR studies. J. Chem. Inf Comput. Sci. 1999, 39, 1037-1041.
67. Estrada, E.; Montero, L.A. Bond order weighted graphs in molecules as structure-property indices. Mol. Eng. 1993, 2, 363-373.
68. Estrada, E.; Ramírez, A. Edge adjacency relationships and molecular topographic descriptors. Definition and QSAR applications. J. Chem. Inf. Comput. Sci. 1997, 37, 837-843.
69. Estrada, E. Three-dimensional molecular descriptors based on electron charge density weighted graphs. J. Chem. Inf Comput. Sci. 1995, 35, 708-713.
70. Estrada, E.; Molina, E. 3D connectivity indices in QSPR/QSAR studies. J. Chem. Inf. Comput. Sci. 2001, 41, 791-797.
71. Dewar, M.J.S.; Zoebish, E.G.; Healy, E.F.; Stewart, J.J.P. AM1: a new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
72. Stewart, J.J.P. MOPAC 6.0, Quantum Chemistry Program Exchange; Indiana University, Bloomington, IN, Program 455.
73. Rodriguez, L.; Estrada, E. MODEST (Molecular DESign Tool) for Windows. Version 3.0; 1999-2000.
74. STATISTICA 6.0; StatSoft Inc.: Tulsa, U.S.A., 2002.
75. Randić, M. Resolution of ambiguities in structure-property studies by us of orthogonal descriptors. J. Chem. Inf. Comput. Sci. 1991, 31, 311-320.
76. Randić, M. Orthogonal molecular descriptors. New J. Chem. 1991, 15, 517-525.
77. Randić, M. Correlation of enthalpy of octanes with orthogonal connectivity indices. J. Mol. Struct. (Theochem) 1991, 233, 45-59.
78. Luèić, B.; Nikolić, S.; Trinajstić, N.; Jurić, D. The structure-property models can he improved using the orthogonalized descriptors. J. Chem. Inf. Comput. Sci. 1995, 35, 532-538.
79. Klein, D.J.; Randić, M.; Babić, D.; Luè;ić, B.; Nikolić, S.; Trinajstić, N. Hierarchical orthogonalization of descriptors. Int. J. Quantum Chem. 1997, 63, 215-222.
80. Stewart, J.J.P. Optimization parameters for semiempirical methods. I. Method. J. Comput. Chem. 1989, 10, 209-220.
81. MacClellan, A.L. Tables of experimental dipole moments; Rahara, 1989.
82. Kotra, L.P.; Xiang, Y.; Newton, M.G.; Schinazi, R.F.; Cheng, Y.-C.; Chu, C.K. Structure-activity relationships of 2-′deoxy-2′,2-′difluoro-L-erythro-pentofuranosyl nucleosides. J. Med. Chem. 1997, 40, 3635-3644.